Activists upend mRNA advances with political power

A Nobel-winning technology harnessed by Trump officials to create Covid shots in record time is becoming a political reject

June 3, 2025 Check out STAT+

Sponsored By

BRENDAN SMIALOWSKI/AFP via Getty Images STAT+ | mRNA, once lauded as a scientific marvel, is now a government target The sharp turnaround on mRNA vaccines shows an unprecedented rise of anti-vaccine activists to power and an attack on accepted science. By Lizzy Lawrence and Isabella Cueto STAT+ | Enhertu, used as first option, stalled tumors for more than a year in women with breast cancer, study finds The findings mean the drug from AstraZeneca and Daiichi Sankyo could set a new standard of care in certain cases. By Adam Feuerstein STAT+ | Bristol Myers to partner with BioNTech on experimental cancer drug The deal, worth billions of dollars, centers on a drug with the dual targets of PD-L1 and VEGF, an approach several companies are pursuing. By Matthew Herper Adobe STAT+ | Defying death two years after brain cancer diagnosis: studies build hope in CAR-T ASCO heard data suggesting that cell therapy may be a way of treating glioblastoma, which has been long seen as incurable. By Angus Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser